These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25129565)

  • 1. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
    Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
    Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
    Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
    Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.
    White NC; Mendo-Lopez R; Papamichael K; Cuddemi CA; Barrett C; Daugherty K; Pollock N; Kelly CP; Alonso CD
    Clin Infect Dis; 2020 Sep; 71(6):1472-1478. PubMed ID: 31584632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.
    Yoon YK; Kim MJ; Sohn JW; Kim HS; Choi YJ; Kim JS; Kim ST; Park KH; Kim SJ; Kim BS; Shin SW; Kim YH; Park Y
    Support Care Cancer; 2014 Aug; 22(8):2039-48. PubMed ID: 24595407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk prediction for 30-day mortality among patients with
    Chiang HY; Huang HC; Chung CW; Yeh YC; Chen YC; Tien N; Lin HS; Ho MW; Kuo CC
    Antimicrob Resist Infect Control; 2019; 8():175. PubMed ID: 31749963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Connecticut medical providers' concordance with 2017 IDSA/SHEA
    Luc CM; Olson D; Banach DB; Clogher P; Hadler J
    Infect Control Hosp Epidemiol; 2021 May; 42(5):549-556. PubMed ID: 33234174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated disease: adherence with current guidelines at a tertiary medical center.
    Curtin BF; Zarbalian Y; Flasar MH; von Rosenvinge E
    World J Gastroenterol; 2013 Dec; 19(46):8647-51. PubMed ID: 24379582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Kidney Injury as a Severity Criteria for
    Carlson TJ; Gonzales-Luna AJ; Nebo K; Chan HY; Tran NT; Antony S; Lancaster C; Alam MJ; Begum K; Garey KW
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa476. PubMed ID: 33209956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with Clostridium difficile treatment guidelines: effect on patient outcomes.
    Crowell KT; Julian KG; Katzman M; Berg AS; Tinsley A; Williams ED; Koltun WA; Messaris E
    Epidemiol Infect; 2017 Aug; 145(11):2185-2192. PubMed ID: 28578710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection.
    Shah DN; Bhatt NS; Welch JK; Koo HL; Garey KW
    J Hosp Infect; 2013 Apr; 83(4):294-9. PubMed ID: 23433867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Guideline Highlights for the Hospitalist: Clostridium difficile Infections in Children.
    Rogers A; ElKadri A
    J Hosp Med; 2020 Feb; 15(2):98-100. PubMed ID: 31634104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):755-757. PubMed ID: 34492699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
    Johnson S; Lavergne V; Skinner AM; Gonzales-Luna AJ; Garey KW; Kelly CP; Wilcox MH
    Clin Infect Dis; 2021 Sep; 73(5):e1029-e1044. PubMed ID: 34164674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Therapies for Clostridioides difficile Infection in Children.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 19. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
    Perry DA; Shirley D; Micic D; Patel PC; Putler R; Menon A; Young VB; Rao K
    Clin Infect Dis; 2022 Jun; 74(11):2028-2035. PubMed ID: 34459885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan.
    Hung YP; Tsai CS; Tsai BY; Tsai PJ; Lee YT; Lee JC; Liu HC; Hsueh PR; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1101-1110. PubMed ID: 33678554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.